Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (Oncolytics) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, provided an...

Related Keywords

Canada ,Canadian ,Timothy Mccarthy ,Jon Patton ,Julie Fleshman ,Matt Coffey ,Clinical Group ,Company Contact ,Oncolytics Biotech Inc ,Securities Exchange ,Nasdaq ,Pancreatic Cancer Action Network Pan ,Esm Program ,Oncolytics Biotech ,Pancreatic Cancer Action Network ,Precision Promise ,Therapeutic Accelerator Award ,Chief Executive Officer ,Therapeutic Accelerator Award Grant ,Securities Exchange Act ,